Current role
Karen Walker
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Karen Walker
Earlier roles on record: CTO at Kyverna Therapeutics, Inc. (KYTX) until February 9, 2026 and Board Member at ELI LILLY & Co (LLY) until December 31, 2024. Kyverna Therapeutics, Inc. reported in an 8-K filed February 3, 2026 that Karen Walker retired as Chief Technology Officer, effective February 9, 2026. ELI LILLY & Co reported in an 8-K filed November 19, 2024 that Karen Walker resigned as member of the Board, effective December 31, 2024. The proxy statement of Kyverna Therapeutics, Inc. reports total compensation of $591,360 for Karen Walker in fiscal 2024, including a base salary of $440,000.
“On January 29, 2026, Karen Walker notified Kyverna Therapeutics, Inc. (the "Company") that she will be retiring from the Company and will cease to serve as the Company's Chief Technology Officer, effective February 9, 2026.”
“In addition, on November 19, 2024, Karen Walker notified the Board of her resignation from the Board effective December 31, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
PagerDuty, Inc. (PD)
Source not stated
Current -
2018-01-01–2024-12-31
-
2018-01-01–2024-12-31
-
Start not stated–2026-02-09
-
Start not stated–2026-02-09
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at PagerDuty, Inc.
Other people whose current roles at this company are on record from its filings.
- Jennifer Tejada CEO, Chairman, Board Member
- John DiLullo CEO, Board Member
- Eric Prengel CFO
- Kathy Chi General Counsel
- Shelley Webb General Counsel
- Howard Wilson Chief Accounting Officer
- Owen Howard Wilson Chief Accounting Officer
- Paul Underwood Chief Accounting Officer
- Alex Shootman Board Member
- Bonita Stewart Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Kyverna Therapeutics, Inc. (KYTX) | Chief Technology Officer | $440,000 | $591,360 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.